XNAS
AMIX
Market cap3mUSD
Jul 28, Last price
1.31USD
1D
-5.76%
1Q
-48.22%
IPO
-74.81%
Name
Autonomix Medical Inc
Chart & Performance
Profile
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY |
---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | |
Income | |||
Revenues | |||
Cost of revenue | 7,555 | 1,990 | |
Unusual Expense (Income) | |||
NOPBT | (7,555) | (1,990) | |
NOPBT Margin | |||
Operating Taxes | (1,990) | ||
Tax Rate | |||
NOPAT | (7,555) | (477) | |
Net income | (15,426) 674.99% | (1,990) -85.07% | |
Dividends | |||
Dividend yield | |||
Proceeds from repurchase of equity | 13,706 | 675 | |
BB yield | -481.63% | ||
Debt | |||
Debt current | |||
Long-term debt | 1,002 | ||
Deferred revenue | |||
Other long-term liabilities | |||
Net debt | (7,606) | (865) | |
Cash flow | |||
Cash from operating activities | (6,648) | (1,854) | |
CAPEX | (19) | ||
Cash from investing activities | (19) | ||
Cash from financing activities | 14,410 | 675 | |
FCF | (7,577) | (477) | |
Balance | |||
Cash | 8,608 | 865 | |
Long term investments | |||
Excess cash | 8,608 | 865 | |
Stockholders' equity | (38,950) | (23,531) | |
Invested Capital | 47,580 | 24,175 | |
ROIC | |||
ROCE | |||
EV | |||
Common stock shares outstanding | 942 | 18,794 | |
Price | 3.02 | ||
Market cap | 2,846 | ||
EV | (4,760) | ||
EBITDA | (7,474) | (1,990) | |
EV/EBITDA | 0.64 | ||
Interest | 79 | ||
Interest/NOPBT |